• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度和尼泊尔高发地区有症状和无症状利什曼原虫感染的发生率:一项前瞻性研究。

Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

机构信息

Institute of Tropical Medicine, Antwerp, Belgium.

出版信息

PLoS Negl Trop Dis. 2011 Oct;5(10):e1284. doi: 10.1371/journal.pntd.0001284. Epub 2011 Oct 4.

DOI:10.1371/journal.pntd.0001284
PMID:21991397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186756/
Abstract

Incidence of Leishmania donovani infection and Visceral Leishmaniasis (VL) was assessed in a prospective study in Indian and Nepalese high-endemic villages. DAT-seroconversion was used as marker of incident infection in 3 yearly surveys. The study population was followed up to month 30 to identify incident clinical cases. In a cohort of 9034 DAT-negative individuals with neither active signs nor history of VL at baseline, 42 VL cases and 375 asymptomatic seroconversions were recorded in the first year, giving an infection:disease ratio of 8.9 to 1. In the 18 months' follow-up, 7 extra cases of VL were observed in the seroconverters group (N=375), against 14 VL cases among the individuals who had not seroconverted in the first year (N=8570) (RR=11.5(4.5<RR<28.3)). Incident asymptomatic L. donovani infection in VL high-endemic foci in India and Nepal is nine times more frequent than incident VL disease. About 1 in 50 of these new but latent infections led to VL within the next 18 months.

摘要

在印度和尼泊尔的高流行地区进行的一项前瞻性研究中,评估了利什曼原虫感染和内脏利什曼病(VL)的发病率。DAT 血清转换被用作 3 年调查中感染的标志物。对研究人群进行了 30 个月的随访,以确定新的临床病例。在基线时 DAT 阴性、无活动性症状或 VL 病史的 9034 名个体中,在第一年记录了 42 例 VL 病例和 375 例无症状血清转换,感染:疾病比为 8.9 比 1。在 18 个月的随访中,在血清转换者组(N=375)中观察到 7 例额外的 VL 病例,而在第一年未发生血清转换的个体中(N=8570)观察到 14 例 VL 病例(RR=11.5(4.5<RR<28.3))。在印度和尼泊尔的 VL 高度流行地区,无症状的利什曼原虫感染比新的 VL 疾病发生的频率高 9 倍。在接下来的 18 个月内,这些新的但潜伏的感染中有 1 例导致 VL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a95/3186756/7743c031e78c/pntd.0001284.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a95/3186756/62cdb87465a1/pntd.0001284.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a95/3186756/7743c031e78c/pntd.0001284.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a95/3186756/62cdb87465a1/pntd.0001284.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a95/3186756/7743c031e78c/pntd.0001284.g002.jpg

相似文献

1
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.印度和尼泊尔高发地区有症状和无症状利什曼原虫感染的发生率:一项前瞻性研究。
PLoS Negl Trop Dis. 2011 Oct;5(10):e1284. doi: 10.1371/journal.pntd.0001284. Epub 2011 Oct 4.
2
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.印度和尼泊尔内脏利什曼病和无症状杜氏利什曼原虫感染的风险因素。
PLoS One. 2014 Jan 31;9(1):e87641. doi: 10.1371/journal.pone.0087641. eCollection 2014.
3
Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.印度比哈尔邦高度流行地区利什曼原虫潜伏感染。
PLoS Negl Trop Dis. 2013;7(2):e2053. doi: 10.1371/journal.pntd.0002053. Epub 2013 Feb 14.
4
Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.从无症状感染到有症状内脏利什曼病进展的决定因素:一项队列研究。
PLoS Negl Trop Dis. 2019 Mar 27;13(3):e0007216. doi: 10.1371/journal.pntd.0007216. eCollection 2019 Mar.
5
Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.在印度和尼泊尔进行的前瞻性队列研究中,血清学状态与进展为临床内脏利什曼病的可能性之间存在强关联。
PLoS Negl Trop Dis. 2014 Jan 23;8(1):e2657. doi: 10.1371/journal.pntd.0002657. eCollection 2014.
6
Seropositivity of Visceral leishmaniasis on people of VL endemic three districts of Nepal.尼泊尔内脏利什曼病流行的三个区人群内脏利什曼病的血清阳性率。
Parasitol Int. 2021 Feb;80:102236. doi: 10.1016/j.parint.2020.102236. Epub 2020 Nov 2.
7
Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes.印度比哈尔邦瓦伊沙利区内脏利什曼病高流行地区的无症状感染:对黑热病消除规划的挑战。
Trans R Soc Trop Med Hyg. 2011 Nov;105(11):661-6. doi: 10.1016/j.trstmh.2011.08.005. Epub 2011 Sep 25.
8
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.无症状感染向有症状内脏利什曼病的转化:对可能的免疫标志物的研究。
PLoS Negl Trop Dis. 2020 Jun 18;14(6):e0008272. doi: 10.1371/journal.pntd.0008272. eCollection 2020 Jun.
9
Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.苏丹东部某流行地区两个村庄中杜氏利什曼原虫感染的流行病学及临床表现
Trop Med Int Health. 2002 Jan;7(1):35-44. doi: 10.1046/j.1365-3156.2002.00832.x.
10
Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study.直接凝集试验在亚临床杜氏利什曼原虫感染早期检测中的应用:一项基于社区的研究。
Ann Trop Med Parasitol. 2005 Dec;99(8):743-9. doi: 10.1179/136485905X65107.

引用本文的文献

1
Systematic suppression of Leishmania (Leishmania) amazonensis-mediated delayed-type hypersensitivity response in American cutaneous leishmaniasis.系统性抑制亚马逊利什曼原虫(利什曼原虫属)介导的美洲皮肤利什曼病迟发型超敏反应。
Parasit Vectors. 2025 Aug 5;18(1):336. doi: 10.1186/s13071-025-06941-6.
2
Clinical Profiles and Outcomes of rK39-Confirmed Paediatric Visceral Leishmaniasis at a General Hospital in Massawa, Eritrea: A Retrospective Study.厄立特里亚马萨瓦一家综合医院经rK39确诊的儿童内脏利什曼病的临床特征与转归:一项回顾性研究
Int J Gen Med. 2025 Jun 26;18:3451-3462. doi: 10.2147/IJGM.S512429. eCollection 2025.
3

本文引用的文献

1
Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.尼泊尔利什曼原虫感染的血清学标志物:直接凝集试验和 rK39 ELISA 的一致性。
Trop Med Int Health. 2010 Nov;15(11):1390-4. doi: 10.1111/j.1365-3156.2010.02631.x.
2
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial.长效杀虫蚊帐预防印度和尼泊尔感染利什曼原虫: 配对群组随机试验。
BMJ. 2010 Dec 29;341:c6760. doi: 10.1136/bmj.c6760.
3
Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India.
Incidence and persistence of asymptomatic Leishmania infection among HIV-infected patients in Trang province, Southern Thailand: A cohort study.
泰国南部董里府 HIV 感染者中无症状利什曼原虫感染的发生率和持续性:一项队列研究。
PLoS Negl Trop Dis. 2024 Oct 8;18(10):e0012581. doi: 10.1371/journal.pntd.0012581. eCollection 2024 Oct.
4
A mathematical model of visceral leishmaniasis transmission and control: Impact of ITNs on VL prevention and elimination in the Indian subcontinent.内脏利什曼病传播和控制的数学模型:在印度次大陆,ITN 对预防和消除内脏利什曼病的影响。
PLoS One. 2024 Oct 4;19(10):e0311314. doi: 10.1371/journal.pone.0311314. eCollection 2024.
5
Effect of indoor residual spraying on sandfly abundance and incidence of visceral leishmaniasis in India, 2016-22: an interrupted time-series analysis and modelling study.2016-2022 年印度室内滞留喷洒对沙蝇密度和内脏利什曼病发病率的影响:一项中断时间序列分析和建模研究。
Lancet Infect Dis. 2024 Nov;24(11):1266-1274. doi: 10.1016/S1473-3099(24)00420-1. Epub 2024 Aug 9.
6
Monitoring of Leishmania transmission in the postelimination phase: The potential of serological surveys.消除后阶段利什曼原虫传播的监测:血清学调查的潜力
Int J Infect Dis. 2024 Oct;147:107153. doi: 10.1016/j.ijid.2024.107153. Epub 2024 Jun 25.
7
Challenges for maintaining post elimination phase of visceral leishmaniasis control programme in India: A field-based study.印度维持内脏利什曼病消除后期控制规划的挑战:基于现场的研究。
PLoS Negl Trop Dis. 2024 Mar 7;18(3):e0012028. doi: 10.1371/journal.pntd.0012028. eCollection 2024 Mar.
8
The immune response in canine and human leishmaniasis and how this influences the diagnosis- a review and assessment of recent research.犬和人利什曼病的免疫反应以及其对诊断的影响——对最新研究的回顾与评估。
Front Cell Infect Microbiol. 2023 Dec 8;13:1326521. doi: 10.3389/fcimb.2023.1326521. eCollection 2023.
9
Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India.班氏丝虫感染与印度比哈尔邦穆扎法尔布尔的内脏利什曼病流行地区向临床内脏利什曼病的进展有关。
PLoS Negl Trop Dis. 2023 Oct 30;17(10):e0011729. doi: 10.1371/journal.pntd.0011729. eCollection 2023 Oct.
10
infecting the carnivore from urban forest fragments in an endemic area of visceral leishmaniasis in Brazilian Midwest.在巴西中西部内脏利什曼病流行地区,从城市森林碎片中的食肉动物身上感染。
Front Cell Infect Microbiol. 2023 Jan 13;12:1050339. doi: 10.3389/fcimb.2022.1050339. eCollection 2022.
印度比哈尔邦一疾病流行区内脏利什曼病的无症状感染。
Am J Trop Med Hyg. 2010 Sep;83(3):502-6. doi: 10.4269/ajtmh.2010.09-0345.
4
Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal.尼泊尔高传播地区利什曼原虫感染的流行病学。
Trop Med Int Health. 2010 Jul;15 Suppl 2:21-8. doi: 10.1111/j.1365-3156.2010.02518.x. Epub 2010 May 6.
5
The epidemiology of Leishmania donovani infection in high transmission foci in India.印度高传播地区感染杜氏利什曼原虫的流行病学。
Trop Med Int Health. 2010 Jul;15 Suppl 2:12-20. doi: 10.1111/j.1365-3156.2010.02519.x. Epub 2010 May 6.
6
Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.牛、沙蝇和人:南亚内脏利什曼病风险因素分析的系统评价及消除的意义。
PLoS Negl Trop Dis. 2010 Feb 9;4(2):e599. doi: 10.1371/journal.pntd.0000599.
7
Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India.印度比哈尔邦内脏利什曼病病例漏报情况估计。
Am J Trop Med Hyg. 2010 Jan;82(1):9-11. doi: 10.4269/ajtmh.2010.09-0235.
8
Visceral leishmaniasis in Aba-Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections.埃塞俄比亚西南部阿巴-罗巴地区的内脏利什曼病:活动性感染和亚临床感染的患病率及发病率
Ann Trop Med Parasitol. 2009 Dec;103(8):659-70. doi: 10.1179/000349809X12554106963555.
9
Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area.流行地区无症状内脏利什曼病血清学诊断检测的比较研究
Am J Trop Med Hyg. 2009 Jul;81(1):27-33.
10
Evaluation of leishmanin skin test in Indian visceral leishmaniasis.印度内脏利什曼病中利什曼原虫皮肤试验的评估
Am J Trop Med Hyg. 2009 Apr;80(4):566-7.